My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

CareDx, Inc. - Common Stock (NQ:CDNA)

19.55 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

3 Analysts Have This To Say About CareDx ↗

November 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

4 Analysts Assess CareDx: What You Need To Know ↗

September 23, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

Where CareDx Stands With Analysts ↗

March 03, 2025

Via Benzinga

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

Breaking Down CareDx: 3 Analysts Share Their Views ↗

January 15, 2025

Via Benzinga

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential ↗

August 26, 2025

CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market.

Via Benzinga

This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗

August 26, 2025

Via Benzinga

CareDx (CDNA) EPS Beats Sales Gain 14% ↗

August 06, 2025

Via The Motley Fool

CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth ↗

August 06, 2025

CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

A Closer Look at 5 Analyst Recommendations For CareDx ↗

October 22, 2024

Via Benzinga

5 Analysts Assess CareDx: What You Need To Know ↗

October 16, 2024

Via Benzinga

Here are the top movers in Thursday's session. ↗

July 17, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

Gapping stocks in Thursday's session ↗

July 17, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings ↗

July 17, 2025

Via Benzinga

Topics Stocks

Analyst Expectations For CareDx's Future ↗

May 05, 2025

Via Benzinga

Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 31, 2025

U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Monday.

Via Benzinga

Topics Stocks

Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

March 31, 2025

Via Benzinga

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta ↗

March 15, 2025

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Via Benzinga

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

February 26, 2025

Via Benzinga

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2025

Via Benzinga

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 ↗

January 14, 2025

Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? ↗

November 26, 2024

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Via Benzinga

Topics Artificial Intelligence

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review ↗

November 08, 2024

A Fed rate cut and a slew of big earnings reports filled out a busy week.

Via Investor's Business Daily

Topics Economy Government

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗

October 31, 2024

The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.

Via Benzinga

Topics ETFs Stocks

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.